Last checked at 10 Mar 2010 07:00
null
Tate & Lyle PLC announces today that Douglas Hurt has been appointed as a Non-Executive Director with effect from 10 March 2010.
Douglas Hurt is Finance Director of IMI plc, the listed international engineering group. Prior to joining IMI plc in 2006, he held a number of financial and operational roles, including US and European senior management positions, at GlaxoSmithKline. He is a member of the Institute of Chartered Accountants.
Sir Peter Gershon, Chairman of Tate & Lyle, said "The Board is delighted that Douglas has agreed to join us. His financial and business management experience will be of great benefit to the Board."
There are no further disclosures to be made in connection with Mr Hurt's appointment pursuant to paragraph 9.6.13 of the Financial Services Authority's Listing Rules.
For more information contact Tate & Lyle PLC:
Chris McLeish, Director of Investor RelationsTel: +44 (0) 20 7977 6211 or Mobile: +44 (0) 7919 102 730
William Baldwin-Charles, Head of Media RelationsTel: +44 (0) 20 7977 6165 or Mobile: +44 (0) 7810 151 425
About Tate & Lyle:
Tate & Lyle is a world-leading renewable food and industrial ingredients company, serving a global market from more than 45 production facilities throughout the Americas, Europe and South East Asia. Our efficient, large-scale manufacturing plants turn agricultural products, corn and cane sugar, into valuable ingredients for our customers. These ingredients add taste, texture, nutrition and increased functionality to products that millions of people around the world use or consume every day.
Tate & Lyle's range of leading branded food ingredients includes SPLENDA® Sucralose, PROMITOR™ Dietary Fiber, STA-LITE® Polydextrose, Tate & Lyle Fairtrade Sugar and Lyle's Golden Syrup. Tate & Lyle also produces branded industrial ingredients including Bio-PDO™, Ethylex® and Sta-Lok® paper starches; and staple ingredients such as high fructose corn syrup, sugar, ethanol, citric acid and basic starches. In addition to providing a wide range of ingredients our expert sales and product applications teams support customers by providing technical advice and proprietary consumer insight studies.
Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2009, Tate & Lyle employed 5,718 people in its subsidiaries and joint ventures, and sales totalled £3.55 billion. http://www.tateandlyle.com.
SPLENDA® is a trademark of McNeil Nutritionals, LLC
Copyright Business Wire 2010